Bristol Myers Squibb drug Augtyro now has a tumor-agnostic approval permitting the drug to be used to treat all solid tumors positive for NTRK gene fusions. Augtyro came from BMS’s $4.1 billion acquisition of Turning Point Therapeutics.

The post New FDA Nod Brings Bristol Myers Squibb Cancer Drug to a Wider Range of Solid Tumors appeared first on MedCity News.

This week, Wheel rolled out a new AI-powered platform designed to provide patients with more holistic and seamless virtual care journeys. The platform, called Horizon, aims to help the startup’s customers rapidly scale virtual care programs to meet growing patient demand.

The post Wheel’s New AI Platform Seeks to Power the New Era of Virtual Care appeared first on MedCity News.

Better Health’s $14 million in funding included investments from Healthworx, the University of Miami Health System and Mosaic General Partnership.

The post Better Health Raises $14M To Reach More Patients with Chronic Conditions appeared first on MedCity News.

Solving this problem will require a multi-pronged approach that includes recruitment, technology, and help from lawmakers.

The post Addressing Healthcare Workforce Shortages Beyond Band-Aids appeared first on MedCity News.

Cutting-edge technology empowers developers to proactively detect and mitigate issues before they cause problems, reducing recalls and fostering trust in the industry.

The post From Recalls to Reliability: Tools to Ensure Software Safety in MedTech appeared first on MedCity News.

The Supreme Court sided with the FDA and unanimously ruled to uphold access to abortion pill mifepristone. The decision quells worries about what it might look like if the Supreme Court sided with the physician group — many healthcare leaders feared that if the top court could overturn mifepristone’s FDA approval, the same could happen to other drugs.

The post How Healthcare Leaders Are Reacting to the Supreme Court Preserving Abortion Pill Access appeared first on MedCity News.

Payers face numerous challenges when it comes to AI, but that doesn’t mean they shouldn’t use the technology, according to Neil Gomes, senior vice president and chief digital officer of AmeriHealth Caritas.

The post AmeriHealth Caritas Exec: Worst Thing Insurers Can Do Is Be Paralyzed by AI Challenges appeared first on MedCity News.

A Pfizer gene therapy for Duchenne muscular dystrophy failed its Phase 3 clinical trial. But analysts draw distinctions between that therapy and Sarepta Therapeutics’ Elevidys, which awaits an FDA decision that could grant it full regulatory approval.

The post Pfizer & Sarepta Gene Therapies Both Failed Phase 3, But Analysts Expect Sarepta Will Win Approval appeared first on MedCity News.

Three things drug manufacturers and CEs can do to build trust and enable effective collaboration

The post How Covered Entities and Pharma Companies Can Better Collaborate on Drug Discount Programs appeared first on MedCity News.

Despite misconceptions about its use, artificial intelligence (AI), through modalities such as machine learning models, is poised to enable companies to expedite the drug design process. 

The post The Potential for AI in Drug Design appeared first on MedCity News.

There is a shortage of GLP-1s in the U.S. But experts have differing opinions on whose responsibility it is to be rationing the drugs.

The post Who Should Be Responsible for Rationing GLP-1s? appeared first on MedCity News.

This month, Moon Surgical received FDA clearance for the commercial version of its Maestro surgical robot system. The system is designed to support surgeons and other operating room staff, specifically for the 18.8 million annual soft tissue surgical procedures not currently supported by available telerobotic systems.

The post Why Is Moon Surgical’s New Commercial Robot System Important? appeared first on MedCity News.

Avidity Biosciences’ RNA therapy for facioscapulohumeral muscular dystrophy has preliminary clinical data showing it knocked down expression of a gene that causes this rare disease. More details will be presented at a medical conference this week.

The post Avidity Bio’s RNA Therapy Flashes Early Signs of Treating a Muscular Dystrophy’s Root Cause appeared first on MedCity News.

Lack of adequate translation and interpreting services isn’t just an inconvenience, it is dangerous and potentially life-threatening.

The post Reimagining the Language and Translation Space for Patients appeared first on MedCity News.

Strengthening patient financial education with the help of digital payment tools could be key to consumer engagement and cash recovery.

The post For Community Hospitals, Curing Payment Confusion Requires Patient Friendly Solutions appeared first on MedCity News.

A report conducted by ATI Advisory and commissioned by Better Medicare Alliance found that Medicare Advantage beneficiaries have lower healthcare spending than fee-for-service Medicare enrollees. This is true across racial and ethnic groups, according to the report.

The post Report: MA Beneficiaries Spend $2,500 Less on Healthcare Than Traditional Medicare Beneficiaries appeared first on MedCity News.

Iqirvo failed as a treatment for the fatty liver disease MASH, but the drug is now FDA approved in primary biliary cholangitis. An Intercept Pharmaceuticals drug already treats this rare liver disease and Gilead Sciences is poised to compete with its PBC drug approaching an FDA decision this summer.

The post Ipsen, Genfit Drug That Missed in MASH Wins FDA Approval in a Much Rarer Liver Disease appeared first on MedCity News.

As with so many other conditions, in vascular health, patients often need to be seen within a few days or weeks, but current referral systems drag on for many weeks and months.

The post How Good Referral Pathways Impact Vascular and Overall Health appeared first on MedCity News.

South Florida-based Mount Sinai Medical Center announced a new remote patient monitoring and chronic care management partnership with HealthSnap, a Miami-based virtual care management platform. The partnership is aimed at improving outcomes among the health system’s Medicare population.

The post Mount Sinai Medical Center Taps HealthSnap to Improve Chronic Conditions Management appeared first on MedCity News.

Getting would-be investors—and the right kind of investors—to notice and care about your company requires a robust strategy.

The post Navigating the Tricky Climate of Health Tech Funding appeared first on MedCity News.

America should be a global leader in healthcare. Instead, we rank last among our peers, and outmoded regulations are holding us back. 

The post How Regulatory Ambiguity is Impeding Healthcare Innovation appeared first on MedCity News.

Skye Bioscience’s nimacimab blocks CB1, the same receptor targeted by an obesity drug candidate now in the hands of Novo Nordisk. But Skye contends its Phase 2-ready antibody drug has several advantages over the small molecule that joined Novo’s pipeline in a deal valued at $1 billion.

The post Skye Bioscience Falls Short in Glaucoma Trial, But It’s Full Steam Ahead for Obesity Program appeared first on MedCity News.

Pelago’s new Inpatient Centers of Excellence network offers Pelago members access to a nationwide network of inpatient substance use disorder treatment centers. The network includes organizations like the Recovery Centers of America and Banyan Treatment Centers.

The post Pelago Launches Inpatient Centers of Excellence Network appeared first on MedCity News.

Stitch PEO — a startup built at Redesign Health — officially launched and announced that it has raised $8.75 million in seed funding. The company is a professional employer organization for independent medical practices, designed to improve recruiting, hiring, onboarding, and other human resources processes.

The post New Startup Launches to Reduce Medical Practices’ HR Burden appeared first on MedCity News.

An experimental Moderna combination vaccine for influenza and Covid-19 showed in a pivotal study that it can elicit a higher immune response compared to vaccines that are already available to protect against infection from both viruses.

The post Moderna’s Flu & Covid-19 Combination Vaccine Succeeds in Phase 3 Clinical Trial appeared first on MedCity News.

How academia and biotech can team up to bring impactful new drug therapies to patients faster

The post Rapid Translation of Therapeutic Discoveries into the Clinic through Purposeful Collaboration appeared first on MedCity News.

Physical and mental health are inextricably intertwined — senior-focused primary care can help bridge the treatment gap

The post Mental Health and Aging: The Role of Primary Care in Overcoming Barriers to Treatment appeared first on MedCity News.

Geron Corporation’s Rytelo is now FDA approved for treating anemia caused by myelodysplastic syndromes. The new drug will compete against Reblozyl, a blockbuster Bristol Myers Squibb medicine.

The post Geron Drug Lands a First-in-Class FDA Approval in Type of Blood Cancer appeared first on MedCity News.

Hospitals need to start thinking about ways to build patients’ trust in generative AI in order for the healthcare industry to fully harness the technology’s potential. They can do this through methods like having transparent conversations, asking for patients’ consent to use the tools and training models on internal data, experts said.

The post What Hospitals Need to Know about Patient Trust in GenAI appeared first on MedCity News.

The biggest generation America has ever seen is officially aging and consuming more MSK care as they do so.

The post Closing the MSK Care Gap in Time for the Silver Tsunami appeared first on MedCity News.